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ccurate and Reproducible Measurement
f Left Ventricular Volume and
jection Fraction by Contrast Echocardiography
Comparison With Magnetic Resonance Imaging
iri Malm, MD,* Sigmund Frigstad, MSC,† Einar Sagberg‡, Henrik Larsson, MD, PHD,*
erje Skjaerpe, MD, PHD*
rondheim, Norway
OBJECTIVES We evaluated the accuracy and reproducibility of contrast echocardiography versus tissue
harmonic imaging for measurements of left ventricular (LV) volumes and ejection fraction
(EF) compared to magnetic resonance imaging (MRI).
METHODS Digital echo recordings of apical LV views before and after intravenous contrast were
collected from 110 consecutive patients. Magnetic resonance imaging of multiple short-axis
LV sections was performed with a 1.5-T scanner. Left ventricular volumes and EF were
calculated offline by method of discs. Thirty randomly selected patients were reanalyzed for
intraobserver and interobserver variability.
RESULTS Compared with baseline, contrast echo increased feasibility for single-plane and biplane
volume analysis from 87% to 100% and from 79% to 95%, respectively. The Bland-Altman
analysis demonstrated volume underestimation by echo, but much less pronounced with
contrast. Limits of agreement between echo and MRI narrowed significantly with contrast:
from 18.1% to 8.3% to 7.7% to 4.1% (EF), from 98.2 to 11.7 ml to 59.0 to 10.7
ml (end-diastolic volume), and from 58.8 to 21.8 ml to 38.6 to 23.9 ml (end-systolic
volume). Ejection fraction from precontrast echo and MRI differed by 10% (EF units) in
23 patients versus 0 after contrast (p  0.001). At intraobserver and interobserver analysis,
limits of agreement for EF narrowed significantly with contrast.
CONCLUSIONS The two-dimensional echocardiographic evaluation of LV volumes and EF in non-selected
cardiac patients was found to be more accurate and reproducible when adding an intravenous
contrast agent. (J Am Coll Cardiol 2004;44:1030–5) © 2004 by the American College of
Cardiology Foundationc
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Veasurements of left ventricular (LV) ejection fraction
EF) by two-dimensional echocardiography (2D-echo) has
een marred by significant observer variability and poor
greement with reference methods (1–3). This has been
mproved by left ventricular opacification (LVO) by second-
eneration intravenous ultrasound contrast agents (4,5), the
ain effect being seen in difficult-to-image patients com-
ared with fundamental imaging (4). Limited data have
een reported comparing tissue harmonic to contrast-
nhanced imaging with adequate reference methods.
The aim of this study was to evaluate whether LVO with
ntravenous contrast has superior accuracy and reproducibil-
ty in 2D-echo assessment of LV volumes and EF compared
o state-of-the-art tissue harmonic imaging in non-selected
From the *Department of Circulation and Medical Imaging and ‡Medical Student,
aculty of Medicine, Norwegian University of Science and Technology, Trondheim,
orway; and †GE Vingmed Ultrasound, Trondheim, Norway. The study was
upported in part by a Research Fellowship grant from the Norwegian Council for
ardiovascular Diseases. Bracco (Italy) and Bristol Myers Squibb (U.S.) provided
ome of the contrast agent used; GE Vingmed Ultrasound (Norway) provided the
esearch ultrasound machine and software.
Manuscript received January 17, 2004; revised manuscript received May 6, 2004,
tccepted May 10, 2004.ardiac patients. Multislice magnetic resonance imaging
MRI) was used as reference standard (6,7).
ETHODS
tudy population. A total of 110 consecutive patients
eferred to the cardiologic department for known or sus-
ected heart disease were enrolled (age above 18 years,
table clinical condition, and sinus rhythm). No screening
or image quality was performed. The exclusion criteria were
enerally accepted contraindications for MRI (metallic im-
lants), pregnancy or lactation, known allergy to the con-
rast agents, significant valve diseases or shunts, and severe
xtracardiac disease. All subjects gave written informed
onsent. The study conformed to the Declaration of Hel-
inki, and the Regional Committee of Medical Ethics
pproved the protocol.
chocardiography. Two second-generation ultrasound
ontrast agents were used; 55 patients received Definity
Bristol-Myers Squibb, North Billerica, Massachusetts), the
ther half SonoVue (Bracco, Milan, Italy). All studies were
erformed by an experienced physician using Vivid 7 (GE
ingmed Ultrasound, Horton, Norway) with the M3Sransducer. The subjects were lying in the left lateral
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September 1, 2004:1030–5 Contrast Echo for EF Measurementsecumbent position. Recordings of standard apical four-
hamber (4CH), two-chamber (2CH), and long-axis
APLAX) views were obtained in baseline tissue harmonic
maging with single and double focus, thereafter with
ontrast using a single-pulse harmonic mode. Power was
djusted to minimize contrast destruction (mechanical index
.22 to 0.31). The contrast agents were administered by a
rained nurse as repeat slow bolus injections of 0.2 (Defin-
ty) and 0.5 ml (SonoVue) through a 20-G vial in a proximal
orearm vein, followed by flushing with at least 5 ml of 0.9%
aline at a speed adjusted to optimize cavity opacification.
his imaging protocol was preferred to multipulse technol-
gy with continuous contrast infusion because of simpler
etup, shorter procedure time, and wider availability. Over-
ll gain, depth, and tissue gain compensation were opti-
ized initially and thereafter kept constant. Special care was
aken to avoid foreshortening of the LV long axis. Cine-
oops of three cardiac cycles per imaging view and modality
ere digitally stored in raw-data format.
All patients fulfilling the imaging protocol were consid-
red for volume analysis. Echocardiographic image quality,
ased on endocardial “traceability” at baseline, was graded
s: 1) very poor (insufficient for volume analysis), 2) poor
analysis possible but difficult), or 3) good (analysis possible
ith confidence).
All cine-loops were assigned random numbers and ana-
yzed by an experienced physician unaware of MRI results
nd patient identity using the modified biplane Simpson’s
ule in EchoPacPC (GE Vingmed Ultrasound). End-
iastole was defined as the frame closest to the R-wave and
nd-systole as the minimal cavity area just before mitral
alve opening. The inner contour of the LV cavity was
anually traced according to the recommendations of the
merican Society of Echocardiography (ASE), leaving the
apillary muscles and trabeculations within the cavity (8).
he end-diastolic volume (EDV) and end-systolic volume
ESV) from three cardiac cycles were averaged, avoiding
ctopic and post-ectopic beats. Ejection fraction was calcu-
ated as: ([EDV  ESV]/EDV)  100%. The APLAX
ather than 2CH view was used in combination with 4CH
iew because of its better acoustic availability and reproduc-
Abbreviations and Acronyms
APLAX  apical long-axis
ASE  American Society of Echocardiography
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
LV  left ventricle
LVO  left ventricular opacification
MRI  magnetic resonance imaging
2CH  two-chamber
2D-echo  two-dimensional echocardiography
4CH  four-chamberbility (9,10). If the APLAX view was not available or the bCH image was clearly of better quality, the 2CH image
as used to maximize feasibility of biplane analysis.
Thirty randomly selected patients were analyzed by an-
ther less experienced observer who was blind to all other
ata. The experienced observer reanalyzed 30 echocardio-
rams in a new random order after a minimum interval of
ight weeks.
RI. Two experienced operators performed the MRI
tudies using a 1.5-T Symphony whole-body system with
uantum Gradients and Syngo 2002B software (Siemens,
rlangen, Germany). Long-axis reference views were used
or positioning the necessary 8 to 12 perpendicular LV
hort-axis slices. Images were collected during breath-hold
8 to 10 s) with prospectively ECG-gated TrueFISP (Fast
maging with Steady-State Precision) sequences. No mag-
etic resonance contrast agent was needed. Section thick-
ess was 6 mm with intersection gaps of 4 mm. Acquisition
ime was 90% of the RR-interval, image matrix 256  150
read/phase), field of view 380 mm, repetition time 52.05
s, echo time 1.74 ms, flip angle 70°, and 12 to 17 heart
hases were acquired per repetition time interval. The
mages were stored and transferred digitally. Echo and MRI
xams were performed within the shortest possible time
nterval. No change in patient medication or clinical con-
ition between the two studies was accepted.
The MRI volumes and EF were calculated by a blinded
nvestigator using a custom-made software programmed in
atLab (The MathWorks, Natick, Massachusetts). Short-
xis endocardial contours were manually traced in end-
iastole (start of R-wave) and in end-systole (smallest cavity
rea). Papillary muscles and trabeculations were, according
o the ASE criteria, included in the LV cavity. The
nd-diastolic and end-systolic cavity surface areas were
ummed up and volumes estimated by multiplying with
nterslice interval.
tatistics. Continuous variables were expressed as mean 
D. Limits of agreement between imaging methods and
etween readings were estimated as mean difference (bias)
2 SD of the differences, as described by Bland and
ltman (11). Interobserver and intraobserver variability
ere also expressed as the standard deviation of difference
able 1. Patient Characteristics (n  100)
ge (yrs) 59 11 (30–83)
en 89
eight (cm) 175 7 (159–194)
ody weight (kg) 80 11 (50–105)
revious myocardial infarction 57
ilated cardiomyopathy 16
ypertension 36
iabetes mellitus 11
V dilation 23
V hypertrophy 34
egional LV dyssynergy 60
alues are mean  SD (range), or number of patients.
LV  left ventricle.etween two readings in percent of the mean. McNemar’s
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Contrast Echo for EF Measurements September 1, 2004:1030–5est was performed to compare the difference between
aired proportions due to the dependent data samples. A
ignificance level of 0.05 was selected.
ESULTS
total of 110 patients completed echo studies. Ten patients
ere excluded: four because of a percutaneous coronary
ntervention being performed and six because of interrupted
r inadequate magnetic resonance examinations. The re-
able 2. Left Ventricular Volumes and EF by MRI, Baseline
chocardiography, and Contrast Echocardiography
MRI
Baseline
Echo
Contrast
Echo
DV (ml) 177.0  60.5 126.1 52.2 152.2 55.1
(90.3–395.0) (48.7–324.0) (80.8–360.7)
SV (ml) 78.7  56.4 63.0  43.8 71.1  48.7
(22.9–298.1) (9.5–227.3) (18.1–252.5)
F (%) 59  14.6 54  12.5 57  13.3
(21–78) (18–80) (22–79)
ean  SD (range).
EDV  end-diastolic volume; EF  ejection fraction; ESV  end-systolic
olume; MRI  magnetic resonance imaging.
igure 1. Echocardiographic end-diastolic (top) and end-systolic (bottom
right) intravenous contrast.aining patient population (n  100) spanned a wide
ariation of LV shapes, sizes, and function (Table 1). In 67
atients the MRI was performed within 1 h, in 20 within 2
ays, and in the remaining within 1 week. A time interval
xceeding 24 h was accepted only with normal LVs and no
ecent myocardial infarction. There were no significant
ifferences in heart rate between echo and MRI studies (66
12 beats/min vs. 68  13 beats/min, p  0.42). Mean
alues of LV volumes and EF are presented in Table 2.
epresentative precontrast and postcontrast echocardio-
rams are shown in Figure 1.
The patients received a mean total dose of 1.48 ml of
onoVue or 0.63 ml Definity. With contrast, procedure
ime was increased by up to 10 min. Except for two patients
xperiencing transient taste disturbances, no side effects
rom contrast injection were observed.
easibility. In 13 patients baseline echo image quality was
ery poor in all apical views, precluding volume analysis. By
dding contrast, all these studies were converted to diag-
ostic. In 75 of the 87 patients analyzable at baseline, the
ombination of 4CH and APLAX views was adequate for
iplane analysis. In 4 of the remaining 12 patients, the 2CH
ges of the apical four-chamber view from a patient before (left) and after) ima
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September 1, 2004:1030–5 Contrast Echo for EF Measurementsubstituted the APLAX view, and in 8 patients only 4CH
ingle-plane analysis was feasible. Corresponding numbers
fter contrast were two and five patients. With contrast,
easibility of single-plane and biplane volume analysis in the
otal population increased from 87% to 100% and from 79%
o 95%, respectively.
ccuracy. In the 87 patients in whom comparisons could
e performed, Bland-Altman analysis of LV volumes and
F from contrast echocardiograms showed significantly
loser agreement with MRI measurements than precontrast
tudies (Fig. 2). Limits of agreement without and with
ontrast were 98.2 to 11.7 ml and 59.0 to 10.7 ml
EDV),58.8 to 21.8 ml and38.6 to 23.9 ml (ESV), and
18.1% to 8.3% and 7.7% to 4.1% (EF, absolute units),
igure 2. Bland-Altman diagrams of end-diastolic volume (EDV), end-sys
solid lines) and limits of agreement (dashed lines) between baseline echoc
chocardiography and MRI (right column). (Bottom panels) closed circle
uality (n  51).espectively. iBaseline echo and MRI EF differed by 10% (EF units)
n 23 patients (26%) versus 0 with contrast (chi-square 
4.2, p 0.001). Seventy-five patients (86%) were correctly
lassified by baseline echo in the appropriate EF group (EF
35%, 35% to 54%, or 55%) based on MRI, whereas
lassification was correct in 86 patients (99%) with contrast
chi-square  8.3, p  0.002).
Baseline image quality was judged as poor in 36 and as
ood in 51 of the 87 analyzable patients. For the “poor”
ubgroup, limits of agreement for EF were 19.9% to 7.9%
t baseline, narrowing to 8.3% to 4.6% after contrast.
orresponding limits of agreement for patients with good
aseline image quality were 16.7% to 9.0% and 7.3% to
.5% (Fig. 2). Between baseline and contrast, the reduction
volume (ESV), and ejection fraction (EF), demonstrating mean difference
raphy and magnetic resonance imaging (MRI) (left column), and contrast
oor baseline image quality (n  36); open circles  good baseline imagetolic
ardiog
s  pn mean differences (bias) for EDV and ESV compared with
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Contrast Echo for EF Measurements September 1, 2004:1030–5RI was 32.0 and 9.7 ml for the “poor” and 30.6 and 12.0
l for the “good” subgroup, respectively (Table 3).
eproducibility. Comparing the readings of two observers,
he limits of agreement for baseline echo were33.3 to 18.1
l (EDV), 23.5 to 16.5 ml (ESV), and 16.6% to 14.2%
EF). With contrast, these limits narrowed to18.8 to 22.6
l (EDV), 15.6 to 14.8 ml (ESV), and 5.9% to 6.9%
EF). At intraobserver analysis, the limits of agreement for
F was 11.1% to 7.8% precontrast, improving to 2.8%
o 2.4% with contrast (Fig. 3). Mean inter- and intraob-
erver variability for EF were reduced from 13.9% to 9.6%
nd from 5.4% to 2.5% without and with contrast,
espectively.
ISCUSSION
ur findings indicate that measurements of LV volumes
nd EF in a non-selected patient population are more
ccurate and reproducible using a second-generation intra-
Table 3. Subgroup Differences in LV Volumes
(n  87)
Subgroup
Poor Baseline Image Qua
Baseline
Echo
Con
E
EDV (ml) –56.4  47.8 –24.4
ESV (ml) –16.2  31.8 –6.5
EF (%) –6.0  13.9 –1.9
Values are mean differences (bias)  2SD of the differences
Abbreviations as in Table 2.
igure 3. Bland-Altman analysis of the interobserver (upper panels) and
y baseline (left) compared to contrast echocardiography (right) (n  30).enous contrast agent, even compared to state-of-the-art
issue harmonic imaging. Contrast injections have previ-
usly been shown to improve measurement of LV volumes
nd EF compared to fundamental imaging (4). Tissue
armonic imaging was indeed used by Thomson et al. (5)
tudying patients post-myocardial infarction, but the sample
ize was relatively small (n  26) and the reference method
as computed tomography, which is less documented by
rospective clinical EF studies. Our study is the first to show
hat LVO is in better agreement with MRI compared to
issue harmonic imaging results.
Echo volume underestimation before contrast was more
ronounced for diastolic than systolic volumes (Fig. 2).
ith contrast, underestimation was reduced, especially for
iastolic volumes. Accordingly, the accuracy of EF measure-
ent improved with significant reduction in limits of
greement. This also indicates that despite tissue harmonic
maging, it is difficult to identify “true” endocardial borders.
EF Between MRI and Echocardiography
Good Baseline Image Quality
Baseline
Echo
Contrast
Echo
.8 –56.3  41.8 –25.7  24.4
.6 –21.8  47.2 –9.0  20.2
–3.8  12.9 –1.4  5.9
its of agreement).
bserver (lower panels) variability of ejection fraction (EF) measurementsand
lity
trast
cho
 23
 15
 6.5
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September 1, 2004:1030–5 Contrast Echo for EF Measurementshe contrast agent is filling the intertrabecular spaces, thus
mproving definition of the outermost endocardial lining
Fig. 1). But the addition of contrast did not eliminate
olume underestimation made by echocardiography, reflect-
ng some of the inherent limitations of transthorasic 2D-
cho such as image plane positioning errors, foreshortening
f the LV long axis, geometric assumptions, and cardiac
ranslation (1,12).
Our data demonstrated a clear improvement in reproduc-
bility of EF measurements by using contrast, both between
bservers with different training and at repeated measurements
y the same observer. The limits of agreement were reduced to
ne-third with contrast compared to baseline. This indicates
hat contrast echo has the potential to improve the confidence
f less experienced investigators, making the interpretation of
V systolic function less operator dependent.
In contrast to Hundley et al. (4), we found that the
dvantage of contrast was also evident for patients with good
mage quality. According to the ASE Task Force Guidelines,
ontrast studies for LVO should be performed in patients with
uboptimal baseline echo studies, in which at least two of six
ontiguous segments in a standard apical view are not visual-
zed (13). However, according to our results, contrast should be
onsidered whenever accurate EF or absolute volumes are
equired for clinical decision making. Contrast should be
articularly useful in serial monitoring of smaller volume or EF
hanges over time, as in post-MI LV remodeling, end-stage
eart failure, heart transplants, cardiotoxic chemotherapy, and
iming of valve replacement in valve regurgitation. Contrast
hould also be considered when LV EF or volumes are used as
nclusion or randomization criteria and outcome parameters in
linical trials.
onclusions. The 2D-echocardiographic evaluation of LV
olumes and EF by tissue harmonic imaging was found to
e more accurate and reproducible when performed after
dding intravenous contrast in non-selected cardiac pa-
ients. Our results support that contrast enhancement
hould be considered not only in very difficult-to-image
atients, but whenever it is considered important to have
recise and repeatable measurements of LV size and global
ystolic performance.eprint requests and correspondence: Dr. Siri Malm, Department
f Circulation and Medical Imaging, Norwegian University of Sci-
nce and Technology, Medisinsk teknisk forskningssenter, N-7489
rondheim, Norway. E-mail: siri.malm@medisin.ntnu.no.
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